Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 106, Issue 1, Pages 39-42Publisher
WILEY
DOI: 10.1002/cpt.1414
Keywords
-
Categories
Ask authors/readers for more resources
The European Medicines Agency (EMA) established the Patient Registry Initiative to explore ways of supporting the use of patient registries in generating high-quality data for regulatory decision making and to enable a systematic approach to their use. We review barriers and opportunities for using patient registries in medicines regulation. A key aspect is that early discussions between all parties may often help address concerns including heterogeneity of data collection, data quality, data sharing, or questions on safety reporting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available